S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

Biomarkers for Cardiovascular Drug Development

A proposal for a context-of-use framework in which circulating biomarkers are assessed along 2 converging “evidence lanes”: analytical readiness and clinical or statistical validation.

T2* MRI Maps Iron in Finger Soft Tissue in Microvasculopathy

Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.

S4 Episode 4: How Confident Should We Be in Psoriasis Biosimilars?

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

10 Medical Breakthroughs Transforming Clinical Care

CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.

Imaging and Staging Essentials in Uveal Melanoma

Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.

Vaccinated Woman With COVID Rebound After Ensitrelvir

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Todays Updates

Chiauranib Slows Platinum-Resistant Ovarian Cancer

The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.

Latest News

A proposal for a context-of-use framework in which circulating biomarkers are assessed along 2 converging “evidence lanes”: analytical readiness and clinical or statistical validation.

Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.

Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

News All Time

Upper GI Disorders: New Evidence May Refine Practice

Dr David Johnson summarizes pivotal DDW 2026 studies, spotlighting emerging evidence across upper GI disorders — from Barrett’s esophagus surveillance to pancreatitis management.

Testosterone Is Back; Have We Learned From Our Mistakes?

A new push to prescribe testosterone replacement therapy led this cardiologist to review the cardiovascular risk data.

The Pitt Season 2: EM Docs Tackle Tough Diagnoses (Part 3)

Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care.

Conference MDAngle: AUA 2026 Metastatic Prostate Cancer

Insights from AUA 2026, including anticipated presentations, key takeaways, and how new research in metastatic prostate cancer will affect patient care.

AUA 2026: Previewing Metastatic Prostate Cancer Updates

Dr Hannah McManus looks ahead to the release of new data from phase 3 clinical trials that will inform multidisciplinary management.

Updates in Ovarian Cancer From SGO 2026

Landmark survival gains in ROSELLA and KEYNOTE-B96 in platinum-resistant disease plus pivotal data in low-grade serous ovarian cancer are highlights from SGO 2026, reported by Dr Amelia Jernigan.

S3 Episode 3: Endometrial Cancer: Research, Early Detection, and Treatment

Drs Ursula Matulonis and Jessica St. Laurent discuss endometrial cancer research, funding, early detection, and treatment, including the impact of GLP-1 receptor agonists.

A Primary Care Primer on Alzheimer’s Blood Tests

Alzheimer’s management may slowly be making its way to primary care, so The Curbsiders unpack the latest on blood-based biomarkers and antiamyloid therapies.

MASH Screening Made Simple: A 4-Step Guide

MASH is incredibly common, but easily missed. Dr Neil Skolnik breaks down the new AGA clinical pathway to help PCPs confidently screen and treat patients.

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Experts review the differential diagnosis of suspected IPF, highlighting how a multidisciplinary approach confirmed the diagnosis and informed selection of optimal antifibrotic therapy.

Adult With Established RA and Symptoms of ILD/PPF

A 50-year-old man with rheumatoid arthritis and symptoms of interstitial lung disease or progressive pulmonary fibrosis is evaluated by experts. Treatment options and care priorities are discussed.

S4 Episode 3: How Much Monitoring Is Enough in Psoriasis Care?

Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

The Half-Life of Medical Certainty

Medical knowledge is always evolving. For his 100th column, Dr Kenny Lin reflects on how his views on cancer screening, blood pressure, and health policy have changed.

Infographic: How Much a Doctor’s Average Pay in the US Rose

On average, a physician in the US earned 3% more in 2025, a Medscape survey found. There was no major difference in compensation gains for primary care doctors vs specialists.

Early Multimodal Therapy Restores Hairline in a Woman

A 36-year-old woman with a 2-year history of hairline recession and eyebrow thinning shows marked regrowth after early multimodal therapy with dutasteride, tofacitinib, and intralesional steroids.

Man With Spinal Compression From Hepatocellular Carcinoma

The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ultimately confirmed metastatic hepatocellular carcinoma.

Recommended News For You

EMA Backs Breast Cancer SERD After FDA No Vote

FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

Clinical trial is testing whether heavy lifting could combat cancer side effects

Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer

younger kidney cancer survivors are more susceptible to heart problems.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Recommended Articles For You

Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians 

Exploring the Causes and Treatments of Cysts: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

2.

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

3.

Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain

4.

GuCS: Genitourinary Cancers Symposium

5.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

1.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

2.

Senescence in Cancer Therapy: Mechanisms, Clinical Relevance, and Therapeutic Implications

3.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

4.

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook

5.

The Latest Research on Chronic Granulomatous Disease and Promising New Treatments 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

3.

Navigating the Complexities of Ph Negative ALL - Part IV

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

5.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot